DXCM · Dexcom Inc
$89.75
-1.73 (-1.89%)
At close · Aug 14
Market Cap
$33.87B
Shares
377.36M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Utilization
60.0%
$600,000,000 used of $1,000,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-05-14 | $1,000,000,000 | $400,000,000 | 2026-06-30 | 2027-06-30 | 10-Q , filed 2026-07-30 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-06-30 YTD | $603,600,000 | 10-Q, filed 2026-07-30 | ||
| 2025-12-31 | $500,000,000 | 10-K, filed 2026-02-12 | ||
| 2024-12-31 | $750,000,000 | 10-K, filed 2026-02-12 | ||
| 2023-12-31 | $688,700,000 | 10-K, filed 2026-02-12 | ||
| 2022-12-31 | $557,700,000 | 10-K, filed 2025-02-18 | ||
| 2021-12-31 | $0 | 10-K, filed 2024-02-08 | ||
| 2020-12-31 | $0 | 10-K, filed 2023-02-09 | ||
| 2019-12-31 | $0 | 10-K, filed 2021-02-11 | ||
| 2018-12-31 | $100,000,000 | 10-K, filed 2021-02-11 | ||
Key facts
CIK
1093557
CUSIP
252131107
13F (30d)
902 filings
871 filers
Visit website
Investor relations